CAS: 197525-99-8
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | TRAM 39 REF: IN-DA01ENNCCAS: 197525-99-8 | 99% | To inquire | Thu 12 Dec 24 |
 | TRAM 39 REF: 3D-XHA52599CAS: 197525-99-8 | Min. 95% | To inquire | Thu 23 Jan 25 |
 | TRAM 39 REF: TM-T23471CAS: 197525-99-8 | 99.51% | 36.00 €~1,095.00 € | Thu 30 Jan 25 |
Ref: IN-DA01ENNC
| 5mg | 170.00 € | ||
| 10mg | 312.00 € | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Thursday 12 Dec 2024
TRAM 39
CAS:197525-99-8
TRAM-39 is a drug that affects the endothelial function in the carotid arteries. It has …
Formula:
C20H14ClN
Purity:
Min. 95%
Molecular weight:
303.8 g/mol
Ref: 3D-XHA52599
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Thursday 23 Jan 2025
TRAM 39
CAS:197525-99-8
TRAM 39 (2-Chloro-α,α-diphenylbenzeneacetonitrile) is a selective blocker of intermediate-conductance Ca2+-activated K+channels.
Formula:
C20H14ClN
Purity:
99.51%
Color and Shape:
Solid
Molecular weight:
303.78
Ref: TM-T23471
| 1mg | 36.00 € | ||
| 2mg | 49.00 € | ||
| 5mg | 74.00 € | ||
| 10mg | 106.00 € | ||
| 25mg | 209.00 € | ||
| 50mg | 332.00 € | ||
| 100mg | 524.00 € | ||
| 500mg | 1,095.00 € |
Estimated delivery in United States, on Thursday 30 Jan 2025
